NCT07192471 2025-09-25A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaKyowa Kirin Co., Ltd.Phase 1 Not yet recruiting72 enrolled
NCT06385522 2025-07-08A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune SystemBoston Immune Technologies and TherapeuticsPhase 1 Not yet recruiting37 enrolled